Feature | March 27, 2013

Biotronik Iforia is World’s First DF4 ICD/CRT-D Approved for MRI

First implantations of the device taking place worldwide

Biotronik Iforia ICD/CRT-D CE-Approval

March 27, 2013 — Biotronik received CE mark for its most advanced ICD/CRT-D (implantable cardioverter defibrillator/cardiac resynchronization therapy device) series. Iforia is the world’s first DF4 ICD/CRT-D series approved for MRI (magnetic resonance imaging). In addition it contains one of the world’s smallest ICDs, the Iforia single chamber ICD.

Aside from featuring ProMRI technology, which allows patients to undergo potentially life-saving MRI scans, Iforia also includes the industry standard DF4 connector system, which is designed to simplify and shorten the implantation procedure. The DF4 connector combines the traditional three connectors into one, allowing for a more convenient implantation procedure without compromising safety.

One of the first implanters, Ching Chi Keong, M.D., of National Heart Centre Singapore, said, “With the Iforia series I can provide my patients with a small and highly reliable ICD and CRT-D series. It includes an impressive range of state-of-the-art innovations including ProMRI and home monitoring. In addition the DF4 technology simplifies the implantation procedure, while the small size of the device makes it more comfortable for the patient and also leads to a better cosmetic result.”

The Iforia series is one of the smallest ICDs and CRT-Ds on the market. In addition the Iforia single chamber ICD has a longevity of more than 11 years and the Iforia CRT-D of more than seven years. This allows for a low replacement rate, benefitting both patients and the healthcare system.

“Safety and reliability are the foundation of all of our new technologies and innovations,” said Christoph Böhmer, president international of Biotronik. “Iforia offers enhanced diagnostic possibilities with the highest reliability and unsurpassed longevity... The new Iforia series combined with ProMRI and Biotronik Home Monitoring offers physicians and patients the best combination of reliability and innovation.”

The European market release of the Iforia series is expected in mid-2013. The first implanters of Biotronik's Iforia ICDs and CRT-Ds are:

  • Prof. Dr. Steffen Behrens, Vivantes Humboldt Hospital Berlin, Germany;
  • Ching Chi Keong, M.D., National Heart Centre Singapore, Singapore;
  • Dr. Thomas Faber, University Heart Centre Freiburg, Germany;
  • Prof. Dr. Stephan B. Felix and Dr. Mathias Busch, University Hospital Greifswald, Germany;
  • Dr. Peter Lercher and Dr. Günther Prenner, LKH-University Clinic Graz, Austria;
  • Abdulmohsen al Musaad, M.D., National Guard Health Affairs Hospital, Riyadh, Saudi Arabia;
  • Dr. Antti Ylitalo and Dr. Tuomas Paana, Satakunta Central Hospital, Pori, Finland.


For more information: www.biotronik.com

Related Content

Siemens Healthineers, Compressed Sensing technology, MRI, FDA approval, RSNA 2017
Technology | Magnetic Resonance Imaging (MRI)| February 21, 2017
Siemens Healthineers announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s Compressed...
News | Cardiac Diagnostics| February 17, 2017
Levels of a protein in the blood associated with heart disease are also linked to early-stage brain damage, according...
Siemens Healthineers, Magnetom Sempra MRI system, FDA approval, RSNA 2017
Technology | Magnetic Resonance Imaging (MRI)| February 17, 2017
Siemens Healthineers announced that the U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sempra 60-cm 1...
Medtronic, expanded indication, Freezor Xtra Cryoablation Catheter, AVNRT, atrioventricular nodal re-entrant tachycardia
Technology | Ablation Systems| February 16, 2017
Medtronic plc announced the U.S. Food and Drug Administration (FDA) has approved its Freezor Xtra Cryoablation Catheter...
Biotronik, ProMRI Configurator tool, MR-conditional cardiac devices, ProMRI SystemCheck
Technology | Implantable Cardiac Monitor (ICM)| February 14, 2017
Biotronik has developed an online tool that streamlines the workflow for physicians selecting the right magnetic...
News | Hypertension| February 13, 2017
Vascular Dynamics Inc. (VDI) announced that the U.S. Food and Drug Administration (FDA) has approved the company’s...
Sir Peter Mansfield, early MRI trials, obituary, University of Nottingham

Sir Peter Mansfield during the original MRI trials. Image courtesy of the University of Nottingham.

Feature | Magnetic Resonance Imaging (MRI)| February 09, 2017 | Jeff Zagoudis
February 9, 2017 — Sir Peter Mansfield, FRS, whose research aided the development of...
Xarelto, rivaroxaban, COMPASS study, ends early,
News | Antiplatelet and Anticoagulation Therapies| February 09, 2017
February 9, 2017 — Janssen Research & Development LLC (Janssen) announced that the Phase 3 COMPASS trial is stopp
GE Healthcare, Freelium technology, MRI magnet cooling, RSNA 2016, RSNA 2017
News | Magnetic Resonance Imaging (MRI)| February 06, 2017
At the 2016 Radiological Society of North America (RSNA) annual meeting, GE Healthcare unveiled Freelium, a magnet...
Technology | Advanced Visualization| February 06, 2017
February 6, 2017 — At the Society of Cardiac Magnetic Resonance (SCMR) 20th Annual Scientific Sessions, GE Healthcare
Overlay Init